Epoprostenol

CHEMBL1139 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
352.5 g/mol
LogP
2.9
Phase
4

This potent medication dilates blood vessels in the lungs and prevents blood clots from forming, helping to reduce the high blood pressure in the pulmonary circulation. It is used to treat severe pulmonary arterial hypertension.

الوزن الجزيئي

352,5000 g/mol

LogP

2,90

TPSA

87,00 Ų

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)O[C@H]2C[C@H]1O

InChI

InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1

Molecular Formula

C20H32O5

HBD / HBA

3 / 5

الروابط القابلة للدوران

10

الذرات الثقيلة

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This potent medication dilates blood vessels in the lungs and prevents blood clots from forming, helping to reduce the high blood pressure in the pulmonary circulation. It is used to treat severe pulmonary arterial hypertension.

Yes, Epoprostenol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1139. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5282411. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.